Focusing on pharmacokinetic and pharmacodynamic mechanisms, Dr Erin C Berthold discusses the interactions between botanical ...

Biomarkers are key to the development of biological drugs, offering vital insights into drug mechanisms of action (MOA), informing clinical study design, and optimizing treatment strategies.

One might expect that researchers would know how methylphenidate works in the brain by now, but little is known about the drug's mechanism of action. Now, a new study seeks to close this gap and ...

In silico design of novel multitarget small molecule inhibitors to treat PTEN-mutant endometrial carcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...

The lead Neumora Therapeutics, Inc. product candidate, Navacaprent, has shown promise in treating major depressive disorder, MDD, and bipolar depression. The lead product candidate, Navacaprent, is a ...

A clear understanding of today’s psychiatric drugs is essential. Emotional issues may call for a medical drug prescription. How the brain functions when medications are used is complex. An important ...